The initiative, which was announced in May, aims to support research using the firm's Codex multiplex tissue imaging platform for single-cell spatial phenotyping and analysis. The new members of I² include the following individuals:

• Omer Bayraktar, PhD, cellular genetics scientific group leader at Wellcome Sanger Institute
• Sami Farhi, PhD, senior research scientist at the Broad Institute of MIT and Harvard
• David Gray, PhD, chief scientific officer at Inscopix
• Sinem Saka, PhD, group leader at the European Molecular Biology Laboratory
• Sizun Jiang, PhD, principal investigator, the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center
• Ruixuan Gao, PhD, assistant professor at the University of Illinois, Chicago
• Cezary Ciszewski, PhD, technical director at the University of Chicago

These investigators, who already have or plan to purchase Codex systems, will be invited to collaborate with other I² members and Akoya subject matter experts, according to the company. Akoya's technology partners will offer additional application support for other specialized imaging platforms, such as confocal or super-resolution microscopes, as well as custom antibody panel content and design, Akoya said.

In addition, network members will be granted first access to prerelease Codex tools and may influence product strategy, according to Akoya.

Codex staining of a human brain tissue sample reveals the presence of biomarkers that enable researchers to visualize cellular organization at the single-cell level and may help identify potential symptoms of diseases such as Alzheimer's. The biomarkers in this image include CD34 (magenta), GFAP (green), neuronal nuclei (red), and α-synuclein (blue). Image courtesy of Akoya Biosciences.